Lv1
20 积分 2024-05-16 加入
IRAK4 inhibitor attenuates inflammation
1个月前
已完结
Targeted Nanocarriers for Systemic Delivery of IRAK4 Inhibitors to Inflamed Tissues
3个月前
已完结
Discovery of LC-MI-3: A Potent and Orally Bioavailable Degrader of Interleukin-1 Receptor-Associated Kinase 4 for the Treatment of Inflammatory Diseases
3个月前
已完结
Teriflunomide suppresses T helper cells and dendritic cells to alleviate experimental autoimmune uveitis
3个月前
已完结
Pathology of experimental autoimmune uveoretinitis in mice
4个月前
已完结
Experimental autoimmune uveoretinitis in mice. induction by a single eliciting event and dependence on quantitative parameters of immunization
4个月前
已完结
The mouse as a model of experimental autoimmune uveoretinitis (EAU)
4个月前
已完结
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design
5个月前
已完结
In Retrospect: Root-Cause Analysis of Structure–Activity Relationships in IRAK4 Inhibitor Zimlovisertib (PF-06650833)
5个月前
已完结
Emerging Co‐Assembled and Sustained Released Natural Medicinal Nanoparticles for Multitarget Therapy of Choroidal Neovascularization
5个月前
已完结
皖公网安备34019202002308
